The healthcare industry in Asia Pacific (APAC), home to half the world's population, faces a dual reality: immense oppor...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the Board of Directors’ decision...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
Eli Lilly and Company has announced a plan to invest more than $6 billion in a new manufacturing facility in Huntsville,...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
Vietnam’s burgeoning tech ecosystem is poised to ignite a vibrant new era of cross-continental collaboration and i...
At the 2nd International Forum of Pharmaceutical Inspectorates (IFPI), held on November 24–25 at the Marriott Hote...
Pillar Biosciences and AstraZeneca have announced an expansion of their existing laboratory access programme for NG...
ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquart...
Australia-based Immutep Limited and Dr. Reddy’s Laboratories, based in India, have announced that their ...
Japan's Santen Pharmaceutical and the Singapore Eye Research Institute (SERI) have launched the Santen–SERI Open I...
South Korea-based Samsung Bioepis Co. has announced the launch of OBODENCE™ (60 mg pre-filled syringe) a...
Japan's Fujitsu Limited has announced the development of a multi-AI agent collaboration technology that enable...
SAI Parenterals Limited (SPL), an India-based pharmaceutical formulation company, has announced the acquisition of a 74....
Beyond tariff cuts, FTAs deliver deep structural benefits through regulatory alignment and facilitation of trade. Firms ...
In both the US and Japan, regulators provide an extensive set of resources detailing the rules and specifications govern...
In today’s global, multi-provider clinical trial environment, sponsors need to rapidly and accurately assess vast ...
In 2026, oncology drug development in Asia may move away from the historical maximum tolerated dose (MTD) paradigm towar...
